EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,500,000 | +160.4% | 178,600 | 0.0% | 0.19% | +175.0% |
| Q3 2020 | $9,025,000 | +6.0% | 178,600 | 0.0% | 0.07% | -12.8% |
| Q2 2020 | $8,514,000 | -2.7% | 178,600 | 0.0% | 0.08% | -33.9% |
| Q1 2020 | $8,750,000 | -14.6% | 178,600 | 0.0% | 0.12% | -7.8% |
| Q4 2019 | $10,250,000 | +59.6% | 178,600 | 0.0% | 0.13% | +45.5% |
| Q3 2019 | $6,424,000 | +15.7% | 178,600 | 0.0% | 0.09% | -29.0% |
| Q2 2019 | $5,551,000 | +32.5% | 178,600 | 0.0% | 0.12% | +6.0% |
| Q1 2019 | $4,188,000 | +70.4% | 178,600 | 0.0% | 0.12% | +14.7% |
| Q4 2018 | $2,458,000 | – | 178,600 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |